Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder

Summary

To determine the anxiolytic efficacy, safety, and tolerability of a flexible-dose of venlafaxine extended release (ER) administered for 16 weeks in the treatment of children and adolescent outpatients with social anxiety disorder (generalized) in a placebo-controlled study.

Timeline

Start

1999-12

Primary completion

—

Completion

2003-06

Drugs

Indications